To include your compound in the COVID-19 Resource Center, submit it here.

Immune reconstitution cell-transfer therapy: Began Phase I trial in 50 patients who will receive monthly infusions

Health Professionals Inc. (HPI),

Read the full 46 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE